Kevin Lin


I partner with entrepreneurs and investors to build ideas into businesses.

Kevin Lin works with emerging technology and life science companies throughout the corporate life cycle, including on early-stage formation and structuring matters, angel and venture financings, commercial transactions, mergers and acquisitions, and general corporate governance matters.

Prior to joining the firm, Kevin was a corporate associate at a large Boston law firm, where he represented public and private companies in a broad range of transactional and corporate counseling matters, including mergers and acquisitions, private equity, venture capital, securities and capital markets and corporate governance.


  • Boston University School of Law, J.D., 2016
  • Cornell University, B.A., 2013

Bar and Court Admissions

  • Massachusetts
  • New York
  • New Hampshire
  • U.S. District Court for the District of New Hampshire


  • Mandarin


  • Alloy Therapeutics as an investor in a number of transactions, including:
    • $42 million Series D financing round led by its existing investors 8VC and Mubadala Capital
    • $75.0 million Series C Financing led by 8VC, Presight Capital and Peter Thiel
    • $21 million Series A Preferred Stock Financing of Vernal Biosciences, a manufacturer of high purity mRNA for research and clinical use
  • Zapata Computing, a quantum software company empowering enterprise teams to accelerate quantum solutions and capabilities, in closing its $38 million Series B financing, led by Comcast Ventures, Pitango and Prelude Ventures
  • RedShift BioAnalytics Inc., a company providing next-generation platform technology enabling measurement of previously undetectable structure changes in biomolecules, in closing its $20 million Series E Preferred Stock financing
  • Global cannabis operator Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in signing a definitive agreement to acquire Green Leaf Medical, LLC, a privately held, fully integrated cannabis multi-state operator based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments
  • Skillsoft in its acquisition of Pluma, a digital professional development and executive-quality coaching platform, for approximately $22 million
  • Ethos Cannabis, a multi-state cannabis operator, in connection with its acquisition of dispensaries in Pennsylvania and Maryland from 4Front Ventures Corp.
  • NASDAQ-listed software company in its acquisition of a micro-app platform company for approximately $200 million.*
  • Biotechnology ecosystem company Alloy Therapeutics, Inc. with the formation of Broadwing Bio LLC, a joint venture with Maze Therapeutics, Inc., to develop targeted antibody therapies for the treatment of ophthalmic diseases
* - Handled prior to joining Foley Hoag


  • “Understanding the Chain of Liability Under HIPAA and How Business Associate Agreements Allocate Risk,” New Hampshire Bar News (January 2018)
  • Lead author, “Solo and Small Firm Cybersecurity Guide: Ethics and Data Security: What Are the Attorney’s Obligations,” New Hampshire Bar News (September 2017)
  • “Know the Law: Protect your company from cyber attacks,” New Hampshire Union Leader (March 2017)
  • Co-author, “Professional service companies face significant cyber risk,” New England In-House (February 2017); also published in New Hampshire Business Review (February 2017)
  • “Know the Law: Some data collecting requires disclosures,” New Hampshire Union Leader (December 2016)
  • Co-author, “Trends in M&A Provisions: Exclusion of Consequential Damages,” Mergers & Acquisitions Law Report, Bloomberg BNA (March 2014)
  • Lead author, “Basketball,” encyclopedia entry for Encyclopedia of Lying and Deception, SAGE Reference (March 2014)

Honors & Involvement

  • Boston University Journal of Science and Technology Law, Note Editor
  • Boston Bar Association
  • Massachusetts Bar Association
  • New Hampshire Bar Association

Speaking Engagements

  • "Exit Strategies for Venture Capital Backed Companies," Angel Capital Association: New England Regional Meeting, 2021